The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.61

Today's change-0.21 -0.35%
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.
 

Bristol-Myers Squibb Co

NYSE: BMY
Last

(U.S.) $60.61

Today's change-0.21 -0.35%
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.

Bristol-Myers Squibb Co down (U.S.)$0.21

Bristol-Myers Squibb Co closed lower Friday, dropping (U.S.)$0.21 or 0.35% to (U.S.)$60.61. Shares have lost 0.75% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 20.32% during the last year.

Key company metrics

  • Open(U.S.) $60.22
  • Previous close(U.S.) $60.82
  • High(U.S.) $61.05
  • Low(U.S.) $59.77
  • Bid / Ask-- / --
  • YTD % change+2.68%
  • Volume5,326,332
  • Average volume (10-day)7,646,312
  • Average volume (1-month)6,334,533
  • Average volume (3-month)6,618,702
  • 52-week range(U.S.) $47.55 to (U.S.) $70.54
  • Beta0.35
  • Trailing P/E56.69×
  • P/E 1 year forward33.07×
  • Forward PEG1.67×
  • Indicated annual dividend(U.S.) $1.48
  • Dividend yield2.44%
  • Trailing EPS(U.S.) $1.07
Updated August 28 4:03 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.71%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue4,1634,0414,2583,921
Total other revenue--------
Total revenue4,1634,0414,2583,921
Gross profit3,1753,2283,3232,950
Total cost of revenue988813935971
Total operating expense4,1182,7524,3183,210
Selling / general / administrative1,1351,0291,3641,200
Research & development9851,0161,139918
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1,14498927192
Other operating expenses, total-134-204-47-71
Operating income451,289-60711
Interest income (expense), net non-operating-49-51-53-50
Gain (loss) on sale of assets8154-3315
Other--------
Income before tax521,448-601,008
Income after tax-1101,19927732
Income tax, total162249-87276
Net income-1301,18613721
Total adjustments to net income--------
Net income before extra. items-1301,18613721
Minority interest-20-13-14-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1301,18613721
Inc. avail. to common incl. extra. items-1301,18613721
Diluted net income-1301,18613721
Dilution adjustment--------
Diluted weighted average shares1,6671,6761,6761,670
Diluted EPS excluding extraordinary itemsvalue per share-0.080.710.010.43
Dividends per sharevalue per share0.370.370.370.36
Diluted normalized EPSvalue per share0.430.660.380.35